Overview
Rho Nutrition develops nutritional supplements, with a focus on a Liposomal NAD+ product designed to support energy production and mitochondrial efficiency. The liposomal delivery method aims to increase NAD+ bioavailability, helping cells convert nutrients into energy more effectively. The company targets adults aged 35 and up seeking anti-aging and wellness benefits and delivers products directly to consumers through its website and marketplaces like Amazon. It differentiates itself by leveraging its founder’s extensive experience in supplement manufacturing, presenting a premium, science-backed option in the longevity space, and emphasizing cellular health rather than just sales volume. The overarching goal is to improve energy, reduce fatigue, and support aging populations with higher-quality, evidence-informed supplements.
Work here?Claim your company
Simplify's take
What believers are saying
- Rho's 2026 revenue reached about $200 million, signaling strong consumer demand.
- Black Friday 2026 sitewide discounts and travel packs expand conversion and repeat purchase opportunities.
- Sprouts distribution and 9,700-plus reviews validate retail traction beyond direct-to-consumer sales.
What critics are saying
- Reuters reported October 28, 2026, Rho is exploring a sale after bank Rothschild involvement.
- Amazon and Sprouts listings expose Rho to copycats, pricing pressure, and channel control loss.
- If FDA challenges NAD+ efficacy claims, Rho's premium longevity brand loses credibility quickly.
What makes Rho Nutrition unique
- Rho sells liposomal NAD+ directly, avoiding NMN precursor dependence and complex clinic channels.
- Its 2026 product pages emphasize 4-milliliter dosing, travel packs, and bundle-based subscription economics.
- Rho claims third-party testing, GMP manufacturing, and 60-day guarantees across its liquid supplement line.
Help us improve and share your feedback! Did you find this helpful?